Expression of HNRNPH3 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

HNRNPH3 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 73.23

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

57.3

Number of samples

141

Samples

Sample	Description	TPM
TCGA-06-5858-01A	0 years, female, white, stage:'--, alive, 187 days	153.0
TCGA-19-1390-01A	0 years, female, white, stage:'--, dead, 772 days	119.3
TCGA-19-5960-01A	0 years, male, white, stage:'--, dead, 455 days	110.4
TCGA-06-0129-01A	0 years, male, asian, stage:'--, dead, 1024 days	109.4
TCGA-06-5417-01A	0 years, female, white, stage:'--, alive, 155 days	108.8
TCGA-28-5215-01A	0 years, female, white, stage:'--, dead, 335 days	98.6
TCGA-41-5651-01A	0 years, female, black or african american, stage:'--, dead, 460 days	96.1
TCGA-06-5408-01A	0 years, female, white, stage:'--, dead, 357 days	94.9
TCGA-27-2523-01A	0 years, male, white, stage:'--, dead, 489 days	94.3
TCGA-06-2570-01A	0 years, female, white, stage:'--, alive, 958 days	93.2
TCGA-76-4925-01A	0 years, male, white, stage:'--, dead, 146 days	92.8
TCGA-12-0618-01A	0 years, male, white, stage:'--, dead, 395 days	89.5
TCGA-32-2634-01A	0 years, male, white, stage:'--, alive, 693 days	89.0
TCGA-28-5207-01A	0 years, male, white, stage:'--, dead, 343 days	86.3
TCGA-02-2483-01A	0 years, male, asian, stage:'--, alive, 466 days	85.9
TCGA-26-5133-01A	0 years, male, white, stage:'--, alive, 452 days	85.8
TCGA-26-1442-01A	0 years, male, white, stage:'--, alive, 953 days	85.3
TCGA-76-4929-01A	0 years, female, white, stage:'--, dead, 111 days	84.4
TCGA-15-1444-01A	0 years, male, white, stage:'--, dead, 1537 days	83.7
TCGA-28-1753-01A	0 years, male, white, stage:'--, alive, 37 days	81.0
TCGA-06-0174-01A	0 years, male, white, stage:'--, dead, 98 days	80.3
TCGA-14-0871-01A	0 years, female, white, stage:'--, dead, 880 days	77.4
TCGA-32-2616-01A	0 years, female, white, stage:'--, dead, 224 days	77.3
TCGA-02-0047-01A	0 years, male, white, stage:'--, dead, 448 days	77.2
TCGA-27-1834-01A	0 years, male, white, stage:'--, dead, 1233 days	76.6
TCGA-06-2559-01A	0 years, male, white, stage:'--, dead, 150 days	76.3
TCGA-19-2624-01A	0 years, male, white, stage:'--, dead, 5 days	76.1
TCGA-32-1970-01A	0 years, male, white, stage:'--, dead, 468 days	74.8
TCGA-06-0686-01A	0 years, male, white, stage:'--, dead, 432 days	74.4
TCGA-06-5413-01A	0 years, male, white, stage:'--, alive, 268 days	73.9
TCGA-06-5416-01A	0 years, female, white, stage:'--, alive, 204 days	73.8
TCGA-08-0386-01A	0 years, male, white, stage:'--, dead, 548 days	73.4
TCGA-28-5208-01A	0 years, male, white, stage:'--, dead, 544 days	73.3
TCGA-76-4931-01A	0 years, female, white, stage:'--, dead, 279 days	73.2
TCGA-14-1034-01A	0 years, female, stage:'--, dead, 485 days	72.9
TCGA-06-2567-01A	0 years, male, white, stage:'--, dead, 133 days	72.9
TCGA-28-5204-01A	0 years, male, white, stage:'--, dead, 454 days	71.9
TCGA-28-5209-01A	0 years, female, white, stage:'--, alive, 442 days	71.6
TCGA-28-5216-01A	0 years, male, white, stage:'--, alive, 415 days	70.5
TCGA-06-5859-01A	0 years, male, white, stage:'--, alive, 139 days	70.2
TCGA-14-0787-01A	0 years, male, asian, stage:'--, dead, 68 days	69.9
TCGA-06-5856-01A	0 years, male, white, stage:'--, dead, 114 days	69.8
TCGA-06-2564-01A	0 years, male, white, stage:'--, alive, 181 days	69.4
TCGA-26-5132-01A	0 years, male, white, stage:'--, alive, 286 days	69.0
TCGA-06-2558-01A	0 years, female, white, stage:'--, dead, 380 days	68.2
TCGA-06-2569-01A	0 years, female, black or african american, stage:'--, alive, 13 days	67.6
TCGA-06-1804-01A	0 years, female, white, stage:'--, dead, 414 days	67.4
TCGA-06-0747-01A	0 years, male, white, stage:'--, dead, 82 days	67.2
TCGA-16-0846-01A	0 years, male, white, stage:'--, dead, 119 days	67.2
TCGA-14-1825-01A	0 years, male, white, stage:'--, dead, 232 days	66.1
TCGA-19-2629-01A	0 years, male, white, stage:'--, dead, 737 days	65.4
TCGA-76-4932-01A	0 years, female, white, stage:'--, dead, 1458 days	65.2
TCGA-12-0619-01A	0 years, male, white, stage:'--, dead, 1062 days	65.1
TCGA-12-0821-01A	0 years, male, white, stage:'--, dead, 323 days	64.8
TCGA-06-0878-01A	0 years, male, white, stage:'--, alive, 218 days	64.7
TCGA-28-5218-01A	0 years, male, white, stage:'--, dead, 157 days	64.7
TCGA-26-5139-01A	0 years, female, white, stage:'--, alive, 48 days	64.1
TCGA-06-2557-01A	0 years, male, black or african american, stage:'--, dead, 33 days	63.9
TCGA-76-4927-01A	0 years, male, white, stage:'--, dead, 535 days	63.7
TCGA-27-2519-01A	0 years, male, white, stage:'--, dead, 550 days	63.4
TCGA-28-2514-01A	0 years, male, asian, stage:'--, alive, 160 days	62.9
TCGA-27-1830-01A	0 years, male, white, stage:'--, dead, 154 days	62.8
TCGA-06-0644-01A	0 years, male, black or african american, stage:'--, dead, 384 days	61.8
TCGA-15-0742-01A	0 years, male, white, stage:'--, dead, 419 days	60.5
TCGA-06-0158-01A	0 years, male, white, stage:'--, dead, 329 days	60.0
TCGA-06-0130-01A	0 years, male, white, stage:'--, dead, 394 days	60.0
TCGA-26-5135-01A	0 years, female, white, stage:'--, dead, 270 days	58.0
TCGA-06-0125-01A	0 years, female, white, stage:'--, dead, 1448 days	57.7
TCGA-27-2528-01A	0 years, male, white, stage:'--, dead, 480 days	55.2
TCGA-06-2565-01A	0 years, male, asian, stage:'--, dead, 506 days	54.5
TCGA-06-0157-01A	0 years, female, white, stage:'--, dead, 97 days	54.3
TCGA-02-2485-01A	0 years, male, black or african american, stage:'--, alive, 470 days	54.1
TCGA-06-2562-01A	0 years, male, white, stage:'--, dead, 382 days	53.0
TCGA-12-3653-01A	0 years, female, white, stage:'--, dead, 442 days	52.8
TCGA-19-2619-01A	0 years, female, black or african american, stage:'--, alive, 294 days	52.7
TCGA-27-2521-01A	0 years, male, white, stage:'--, dead, 510 days	52.6
TCGA-32-2615-01A	0 years, male, white, stage:'--, dead, 485 days	52.0
TCGA-12-5299-01A	0 years, female, white, stage:'--, dead, 98 days	51.3
TCGA-06-0211-01A	0 years, male, white, stage:'--, dead, 360 days	50.7
TCGA-28-5220-01A	0 years, male, white, stage:'--, dead, 388 days	50.2
TCGA-06-0744-01A	0 years, male, white, stage:'--, dead, 1426 days	50.2
TCGA-06-0646-01A	0 years, male, white, stage:'--, dead, 175 days	49.7
TCGA-27-1832-01A	0 years, female, white, stage:'--, dead, 300 days	49.7
TCGA-06-2561-01A	0 years, female, white, stage:'--, dead, 537 days	49.0
TCGA-06-0238-01A	0 years, male, white, stage:'--, dead, 405 days	48.8
TCGA-06-5411-01A	0 years, male, white, stage:'--, dead, 254 days	48.7
TCGA-06-0882-01A	0 years, male, white, stage:'--, dead, 632 days	48.5
TCGA-06-5414-01A	0 years, male, white, stage:'--, alive, 273 days	48.3
TCGA-41-3915-01A	0 years, male, white, stage:'--, dead, 360 days	48.3
TCGA-06-2563-01A	0 years, female, white, stage:'--, alive, 932 days	47.7
TCGA-19-2620-01A	0 years, male, white, stage:'--, dead, 148 days	47.7
TCGA-32-2638-01A	0 years, male, white, stage:'--, dead, 766 days	47.6
TCGA-28-2509-01A	0 years, female, white, stage:'--, alive, 145 days	47.5
TCGA-27-1837-01A	0 years, male, white, stage:'--, dead, 427 days	47.4
TCGA-14-0789-01A	0 years, male, white, stage:'--, dead, 342 days	47.3
TCGA-06-0187-01A	0 years, male, white, stage:'--, dead, 828 days	46.8
TCGA-06-0190-01A	0 years, male, white, stage:'--, dead, 317 days	45.8
TCGA-02-2486-01A	0 years, male, white, stage:'--, dead, 618 days	45.8
TCGA-41-4097-01A	0 years, female, white, stage:'--, dead, 6 days	45.5
TCGA-06-0156-01A	0 years, male, white, stage:'--, dead, 178 days	45.2
TCGA-32-2632-01A	0 years, male, white, stage:'--, dead, 269 days	44.7
TCGA-06-5410-01A	0 years, female, white, stage:'--, dead, 108 days	44.4
TCGA-12-0616-01A	0 years, female, white, stage:'--, dead, 448 days	44.2
TCGA-27-1835-01A	0 years, female, white, stage:'--, dead, 648 days	44.2
TCGA-06-5412-01A	0 years, female, white, stage:'--, dead, 138 days	43.1
TCGA-19-4065-01A	0 years, male, white, stage:'--, alive, 214 days	42.5
TCGA-06-0743-01A	0 years, male, white, stage:'--, dead, 803 days	42.5
TCGA-06-5418-01A	0 years, female, white, stage:'--, dead, 83 days	41.1
TCGA-02-0055-01A	0 years, female, white, stage:'--, dead, 76 days	40.6
TCGA-06-0168-01A	0 years, female, white, stage:'--, dead, 598 days	40.1
TCGA-06-0645-01A	0 years, female, white, stage:'--, dead, 175 days	39.7
TCGA-32-5222-01A	0 years, male, white, stage:'--, dead, 585 days	39.2
TCGA-06-0745-01A	0 years, male, white, stage:'--, dead, 239 days	39.2
TCGA-32-1980-01A	0 years, male, white, stage:'--, dead, 36 days	36.7
TCGA-12-3650-01A	0 years, male, white, stage:'--, dead, 333 days	36.1
TCGA-06-0749-01A	0 years, male, black or african american, stage:'--, dead, 82 days	35.7
TCGA-06-0750-01A	0 years, male, white, stage:'--, dead, 28 days	33.6
TCGA-06-0210-01A	0 years, female, white, stage:'--, dead, 225 days	32.2
TCGA-41-2572-01A	0 years, male, white, stage:'--, dead, 406 days	31.6
TCGA-41-2571-01A	0 years, male, white, stage:'--, dead, 26 days	31.1
TCGA-28-2513-01A	0 years, female, white, stage:'--, alive, 222 days	30.6
TCGA-06-0184-01A	0 years, male, white, stage:'--, dead, 2126 days	30.3
TCGA-32-1982-01A	0 years, female, white, stage:'--, dead, 142 days	29.3
TCGA-12-5295-01A	0 years, female, white, stage:'--, dead, 454 days	29.0
TCGA-19-2625-01A	0 years, female, white, stage:'--, dead, 124 days	27.8
TCGA-26-5134-01A	0 years, male, white, stage:'--, alive, 167 days	27.4
TCGA-27-2524-01A	0 years, male, white, stage:'--, dead, 231 days	26.7
TCGA-14-2554-01A	0 years, female, white, stage:'--, dead, 532 days	26.5
TCGA-27-2526-01A	0 years, female, white, stage:'--, dead, 87 days	25.9
TCGA-06-0141-01A	0 years, male, white, stage:'--, dead, 313 days	24.0
TCGA-06-0132-01A	0 years, male, white, stage:'--, dead, 771 days	23.7
TCGA-06-0138-01A	0 years, male, white, stage:'--, dead, 737 days	21.9
TCGA-12-3652-01A	0 years, male, white, stage:'--, dead, 1062 days	21.9
TCGA-32-4213-01A	0 years, female, white, stage:'--, alive, 604 days	20.8
TCGA-06-0139-01A	0 years, male, white, stage:'--, dead, 362 days	19.8
TCGA-14-0817-01A	0 years, female, white, stage:'--, dead, 164 days	18.9
TCGA-14-1823-01A	0 years, female, white, stage:'--, dead, 543 days	16.1
TCGA-27-1831-01A	0 years, male, white, stage:'--, dead, 505 days	14.9
TCGA-06-0178-01A	0 years, male, white, stage:'--, dead, 2681 days	14.3
TCGA-06-0219-01A	0 years, male, white, stage:'--, dead, 22 days	13.8
TCGA-14-1829-01A	0 years, male, black or african american, stage:'--, alive, 218 days	11.0
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

HNRNPH3 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 6.56

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average TPM

8.4

Number of samples

Samples

Sample	Description	TPM
AK035	N, NA, stage:NA, dead, 210 days	26.1
AK006	N, NA, stage:NA, dead, 360 days	23.6
AK043	N, NA, stage:NA, alive, 660 days	21.3
AK102	N, NA, stage:NA, alive, 1740 days	18.6
AK085	N, NA, stage:NA, alive, 660 days	16.4
AK081	N, NA, stage:NA, dead, 180 days	15.7
AK002	N, NA, stage:NA, dead, 570 days	15.7
AK079	N, NA, stage:NA, dead, 210 days	14.4
AK117	N, NA, stage:NA, dead, 210 days	13.9
AK123	N, NA, stage:NA, dead, 180 days	13.8
AK041	N, NA, stage:NA, alive, 810 days	13.3
AK099	N, NA, stage:NA, dead, 420 days	13.3
AK133	N, NA, stage:NA, dead, 360 days	13.1
AK226	N, NA, stage:NA, dead, 360 days	13.1
AK134	N, NA, stage:NA, dead, 360 days	12.6
AK205	N, NA, stage:NA, dead, 120 days	11.3
AK103	N, NA, stage:NA, alive, 1320 days	10.4
AK005	N, NA, stage:NA, dead, 240 days	10.2
AK089	N, NA, stage:NA, dead, 330 days	9.1
AK051	N, NA, stage:NA, dead, 360 days	8.8
AK227	N, NA, stage:NA, alive, 300 days	8.7
AK218	N, NA, stage:NA, dead, 180 days	7.6
AK015	N, NA, stage:NA, alive, 720 days	7.6
AK124	N, NA, stage:NA, alive, 1920 days	7.4
AK066	N, NA, stage:NA, alive, 960 days	6.9
AK195	N, NA, stage:NA, dead, 390 days	6.7
AK199	N, NA, stage:NA, alive, 1860 days	6.6
AK088	N, NA, stage:NA, dead, 360 days	6.5
AK030	N, NA, stage:NA, dead, 120 days	6.4
AK149	N, NA, stage:NA, dead, 420 days	6.4
AK173	N, NA, stage:NA, dead, 180 days	6.1
AK156	N, NA, stage:NA, dead, 330 days	5.8
AK231	N, NA, stage:NA, dead, 240 days	5.8
AK216	N, NA, stage:NA, dead, 360 days	5.7
AK049	N, NA, stage:NA, dead, 180 days	5.7
AK091	N, NA, stage:NA, dead, 210 days	5.4
AK068	N, NA, stage:NA, alive, 360 days	5.3
AK076	N, NA, stage:NA, alive, 660 days	5.2
AK158	N, NA, stage:NA, dead, 360 days	5.1
AK165	N, NA, stage:NA, alive, 360 days	5.1
AK053	N, NA, stage:NA, dead, 300 days	5.1
AK100	N, NA, stage:NA, alive, 960 days	4.8
AK003	N, NA, stage:NA, dead, 600 days	4.7
AK071	N, NA, stage:NA, dead, 540 days	4.7
AK188	N, NA, stage:NA, alive, 420 days	4.5
AK167	N, NA, stage:NA, dead, 180 days	4.3
AK142	N, NA, stage:NA, alive, 90 days	4.2
AK074	N, NA, stage:NA, alive, 300 days	4.1
AK153	N, NA, stage:NA, dead, 240 days	4.1
AK213	N, NA, stage:NA, alive, 2010 days	4.0
AK178	N, NA, stage:NA, dead, 240 days	3.9
AK055	N, NA, stage:NA, dead, 240 days	3.6
AK098	N, NA, stage:NA, dead, 660 days	3.4
AK183	N, NA, stage:NA, alive, 360 days	3.4
AK185	N, NA, stage:NA, alive, 330 days	3.3
AK236	N, NA, stage:NA, dead, 360 days	3.1
AK072	N, NA, stage:NA, dead, 150 days	3.0
AK139	N, NA, stage:NA, dead, 270 days	2.7
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0218770003	Tumor	1.2
CPT0189570004	Tumor	0.8
CPT0087730003	Tumor	0.6
CPT0078580003	Tumor	0.6
CPT0161730003	Tumor	0.6
CPT0190240004	Tumor	0.5
CPT0217190003	Tumor	0.5
CPT0207090003	Tumor	0.5
CPT0228220003	Tumor	0.5
CPT0208980003	Tumor	0.4
CPT0206780003	Tumor	0.4
CPT0182550003	Tumor	0.4
CPT0206670004	Tumor	0.4
CPT0224390004	Tumor	0.4
CPT0087680003	Tumor	0.3
CPT0206230003	Tumor	0.3
CPT0205780003	Tumor	0.3
CPT0217880003	Tumor	0.2
CPT0089150003	Tumor	0.2
CPT0123530003	Tumor	0.2
CPT0167530003	Tumor	0.2
CPT0205670004	Tumor	0.2
CPT0071100003	Tumor	0.2
CPT0218830004	Tumor	0.2
CPT0189250003	Tumor	0.2
CPT0217100003	Tumor	0.2
CPT0064890003	Tumor	0.2
CPT0218670003	Tumor	0.2
CPT0168380003	Tumor	0.2
CPT0168080003	Tumor	0.2
CPT0182500003	Tumor	0.1
CPT0217710008	Tumor	0.1
CPT0218330004	Tumor	0.1
CPT0189460003	Tumor	0.1
CPT0167860004	Tumor	0.1
CPT0092440003	Tumor	0.1
CPT0168480003	Tumor	0.1
CPT0205890003	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0206560003	Tumor	0.1
CPT0217430008	Tumor	0.1
CPT0162140003	Tumor	0.1
CPT0224540004	Tumor	0.1
CPT0064650003	Tumor	0.1
CPT0125220003	Tumor	0.1
CPT0093450003	Tumor	0.1
CPT0125570003	Tumor	0.1
CPT0162020003	Tumor	0.1
CPT0093550003	Tumor	0.0
CPT0204350003	Normal	0.0
CPT0093360003	Tumor	0.0
CPT0087570003	Tumor	0.0
CPT0127420003	Tumor	0.0
CPT0002410011	Tumor	0.0
CPT0205570003	Tumor	0.0
CPT0104330003	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0171580008	Tumor	0.0
CPT0079790003	Tumor	0.0
CPT0207030003	Tumor	0.0
CPT0087950003	Tumor	0.0
CPT0218890004	Tumor	-0.1
CPT0201710003	Tumor	-0.1
CPT0206330003	Tumor	-0.1
CPT0218960004	Tumor	-0.1
CPT0204370003	Normal	-0.1
CPT0182580003	Tumor	-0.1
CPT0168830003	Tumor	-0.1
CPT0167640003	Tumor	-0.1
CPT0221180003	Tumor	-0.1
CPT0217060003	Tumor	-0.1
CPT0175060003	Tumor	-0.1
CPT0168720003	Tumor	-0.1
CPT0217000004	Tumor	-0.1
CPT0125510003	Tumor	-0.1
CPT0204330003	Normal	-0.1
CPT0225760003	Tumor	-0.1
CPT0206450003	Tumor	-0.1
CPT0093590003	Tumor	-0.1
CPT0225730003	Tumor	-0.1
CPT0204390003	Normal	-0.1
CPT0167970003	Tumor	-0.1
CPT0204360003	Normal	-0.2
CPT0205450004	Tumor	-0.2
CPT0206000004	Tumor	-0.2
CPT0224330003	Tumor	-0.2
CPT0162100003	Tumor	-0.2
CPT0186100003	Tumor	-0.2
CPT0224600003	Tumor	-0.2
CPT0204340003	Normal	-0.2
CPT0167750004	Tumor	-0.2
CPT0209440003	Tumor	-0.2
CPT0104220003	Tumor	-0.2
CPT0219080004	Tumor	-0.2
CPT0127480003	Tumor	-0.2
CPT0189750004	Tumor	-0.2
CPT0189650004	Tumor	-0.2
CPT0168590003	Tumor	-0.2
CPT0199770003	Tumor	-0.3
CPT0216920008	Tumor	-0.3
CPT0093510003	Tumor	-0.3
CPT0168270003	Tumor	-0.3
CPT0204420003	Normal	-0.3
CPT0204410003	Normal	-0.3
CPT0206880003	Tumor	-0.3
CPT0218690004	Tumor	-0.3
CPT0204400003	Normal	-0.3
CPT0204380003	Normal	-0.3
CPT0196850003	Tumor	-0.3
CPT0190360004	Tumor	-0.4
Show allShow less

GLIOMA - Protein expressionⁱ

Pending cancer tissue analysis